Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Institute Wins Grant for Antibiotic Resistance Surveillance

NEW YORK (GenomeWeb) – The Wellcome Trust Sanger Institute announced today that its Centre for Genomic Pathogen Surveillance has been selected to house a global health research unit to monitor antibiotic-resistant bacteria across the world.

The initiative is being funded with a £6.8 million ($8.8 million) grant from the UK's National Institute of Health Research. With the money, the research unit will coordinate the activities of national laboratories in the Philippines, India, Nigeria, and Colombia to provide surveillance data for bacterial pathogens using whole-genome sequencing. It will also provide the labs with resources and training in genomic methods to enhance local capacity for spotting and tracking resistant strains.

"Through sampling and sequencing the DNA of resistant and sensitive bacteria within these strategically relevant countries, we will enhance local research capacity while feeding data into national and international surveillance for monitoring and spotting the emergence of resistance," David Aanensen, director of the Centre for Genomic Pathogen Surveillance, said in a statement. "The information from these units will ultimately help to improve the public health response of entire regions."

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.